Story thread · 3 reports / 2 sources

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

financialpost.com · 11dShare

VANCOUVER, BC and BOSTON, MA, July 31, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to eleven new non-officer employees consisting of an aggregate of 32,758 share options and 19,013 […]

First report: Xenon to Report Q2 2026 Financial Results on August 6, 2026 — financialpost.com, 12d